Allium compounds, dipropyl and dimethyl thiosulfinates as antiproliferative and differentiating agents of human acute myeloid leukemia cell lines.
Epidemiologic studies support the premise that Allium vegetables may lower the risk of cancers. The beneficial effects appear related to the organosulfur products generated upon processing of Allium. Leukemia cells from patients with acute myeloid leukemia (AML) display high proliferative capacity and have a reduced capacity of undergoing apoptosis and maturation. Whether the sulfur-containing molecules thiosulfinates (TS), diallyl TS (All(2)TS), dipropyl TS (Pr(2)TS) and dimethyl TS (Me(2)TS), are able to exert chemopreventative activity against AML is presently unknown. The present study was an evaluation of proliferation, cytotoxicity, differentiation and secretion of AML cell lines (U937, NB4, HL-60, MonoMac-6) in response to treatment with these TS and their related sulfides (diallylsulfide, diallyl disulfide, dipropyl disulfide, dimethyl disulfide). As assessed by flow cytometry, ELISA, gelatin zymogaphy and RT-PCR, we showed that Pr(2)TS and Me(2)TS, but not All(2)TS and sulfides, 1) inhibited cell proliferation in dose- and time-dependent manner and this process was neither due to cytotoxicity nor apoptosis, 2) induced macrophage maturation, and 3) inhibited the levels of secreted MMP-9 (protein and activity) and TNF-alpha protein, without altering mRNA levels. By establishing for the first time that Pr(2)TS and Me(2)TS affect proliferation, differentiation and secretion of leukemic cell lines, this study provides the opportunity to explore the potential efficiency of these molecules in AML.
Merhi
Faten
F
UMR 7131 UPMC Paris Universitas/ CNRS, Groupe Hospitalier Broussais-HEGP, Paris, France.
Auger
Jacques
J
Rendu
Francine
F
Bauvois
Brigitte
B
Biochim Biophys Acta. 2000 Mar 27;1470(2):M55-62
10722927
Cardiovasc Hematol Agents Med Chem. 2006 Jan;4(1):33-52
16529548
Blood Rev. 2006 Mar;20(2):71-82
16185796
Biologics. 2007 Dec;1(4):415-24
19707311
Carcinogenesis. 2006 Mar;27(3):533-40
16169930
J Immunol. 1990 Feb 15;144(4):1311-6
2105994
J Cell Sci. 1993 Apr;104 ( Pt 4):991-9
8314909
J Chromatogr A. 2006 Apr 21;1112(1-2):3-22
16388813
Cancer Res. 2001 Jan 1;61(1):2-7
11196162
Biochem Pharmacol. 2000 Nov 15;60(10):1475-83
11020449
J Chromatogr A. 2003 Mar 28;991(1):69-75
12703902
Acta Haematol. 2004;111(1-2):107-23
14646349
Leuk Res. 1998 Jun;22(6):537-47
9678720
Blood. 1990 Feb 1;75(3):626-32
2153423
Stem Cells Dev. 2004 Oct;13(5):484-95
15588506
Cancer Res. 2003 Oct 15;63(20):6825-37
14583480
Platelets. 2007 Nov;18(7):481-90
17852771
Blood. 2003 Jun 15;101(12):4667-79
12623839
Cancer Metastasis Rev. 2006 Mar;25(1):9-34
16680569
J Nutr. 2006 Mar;136(3 Suppl):716S-725S
16484550
J Immunol Methods. 2002 Jan 1;259(1-2):55-64
11730841
J Nutr. 2006 Mar;136(3 Suppl):827S-831S
16484574
Carcinogenesis. 1996 Apr;17(4):669-73
8625476
Curr Oncol Rep. 2007 Sep;9(5):337-44
17706161
Cell Biol Toxicol. 2004 Jul;20(4):253-60
15499972
Life Sci. 2002 Jun 14;71(4):411-9
12044841
Cell Death Differ. 2006 May;13(5):748-58
16498458
J Nutr. 2001 Mar;131(3s):1058S-60S
11238816
Cancer. 2008 Feb 1;112(3):572-80
18085638
Leukemia. 2004 Feb;18(2):227-32
14671638
J Cell Biochem Suppl. 1997;27:106-12
9591200
J Nutr. 2006 Mar;136(3 Suppl):810S-812S
16484570
Eur J Immunol. 1999 Sep;29(9):3009-16
10508275
Leukemia. 2002 May;16(5):791-8
11986939
Crit Rev Food Sci Nutr. 2004;44(6):479-88
15615431
Blood. 1999 Sep 15;94(6):1971-8
10477726
Drug Metabol Drug Interact. 2000;17(1-4):51-79
11201304
Acta Haematol. 2001;106(4):190-207
11815717
Leukemia. 2007 Aug;21(8):1605
17637714
Blood. 1991 Mar 1;77(5):1080-6
1995093
Lancet Neurol. 2003 Dec;2(12):747-56
14636780
Biochim Biophys Acta. 1996 Jan 17;1315(1):15-20
8611641
J Clin Invest. 2001 Sep;108(6):851-9
11560954
Nat Rev Immunol. 2004 Aug;4(8):617-29
15286728
Crit Rev Oncol Hematol. 2004 May;50(2):87-100
15157658
Biologics. 2008 Mar;2(1):143-9
19707437
J Hematother Stem Cell Res. 2002 Feb;11(1):33-47
11847002
J Exp Med. 1995 Nov 1;182(5):1545-56
7595224
Leuk Res. 1991;15(6):409-18
1861527
Biochem Pharmacol. 2002 Jan 1;63(1):41-7
11754872
Leukemia. 2002 Oct;16(10):2062-71
12357358
Mol Cancer Ther. 2005 Sep;4(9):1388-98
16170031
J Biol Chem. 2005 Dec 16;280(50):41487-93
16219763
Blood. 2001 Jun 15;97(12):3919-24
11389035
J Biol Chem. 2004 Apr 23;279(17):17772-84
14754893
Blood. 1994 Jul 1;84(1):294-302
7517212
Oncologist. 2007;12 Suppl 2:14-21
18039635
Mutat Res. 2004 Nov 2;555(1-2):121-31
15476856
Arch Intern Med. 2001 Mar 26;161(6):813-24
11268223
Leuk Res. 2008 Feb;32(2):315-22
17561254
Thromb Haemost. 2001 Nov;86(5):1284-91
11816719
Blood. 1997 Mar 15;89(6):1870-5
9058706
Int J Cancer. 2000 Jun 15;86(6):768-76
10842189
Haematologica. 2007 Sep;92(9):1224-9
17666366
Blood. 1987 Nov;70(5):1233-44
3311197
J Biol Chem. 2001 Nov 30;276(48):45491-6
11585813
Leukemia. 1999 Jun;13(6):835-42
10360369
J Nutr. 2003 Jul;133(7):2171-5
12840173